MedTrace Logo

To Evaluate the Efficacy and Safety of Collavant n2 in Individuals With Osteoarthritis of the Knee

NCT05474586 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 236

Last updated 2023-09-06

No results posted yet for this study

Summary

A randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of Collavant n2 in individuals with osteoarthritis of the knee.

Conditions

  • Osteoarthritis, Knee

Interventions

OTHER

Collavant n2 40 mg/day

2 capsules in the morning before breakfast and 2 capsules at night before going to bed for 180 days

OTHER

Glucosamine hydrochloride & Chondroitin sulfate

2 capsules in the morning before breakfast and 2 capsules at night before going to bed for 180 days

OTHER

Microcrystalline cellulose

2 capsules in the morning before breakfast and 2 capsules at night before going to bed for 180 days

Sponsors & Collaborators

  • Vedic Lifesciences Pvt. Ltd.

    lead INDUSTRY

Principal Investigators

  • Dr Shalini Srivastava, MD medicine · Vedic Lifesciences Pvt. Ltd.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-08-08
Primary Completion
2023-07-04
Completion
2023-07-04

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05474586 on ClinicalTrials.gov